Omnix Medical
Omnix Medical is a clinical-stage biopharmaceutical company developing next-generation of anti-infective drugs to overcome the threat of Antimicrobial Resistance. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€14m (Public information from Oct 2020)
Company register number 515236784
Jerusalem Jerusalem District (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $910k | Seed | |
€2.4m | Grant | ||
N/A | Early VC | ||
$3.3m Valuation: $15.3m | Series A | ||
* | N/A | N/A | - |
N/A | Seed | ||
Total Funding | €6.2m |
Related Content
Recent News about Omnix Medical
EditMore about Omnix Medical
EditDeveloper of an antimicrobial drug technology designed to develop and commercialize highly effective antibiotic agents. The company's technology develops antibiotics for the treatment of life-threatening infections involving multi-drug resistant bacteria, enabling pharmaceutical clients to provide a cure for people who suffer from infections associated with resistant bacteria.
Keywords: Pharmaceuticals and Biotechnology, Antibiotic Agent, Antimicrobial Resistance, Bacterial Infection, Biopharmaceutical Company, First Line, Mdr Bacteria, Novel Antibiotics, Pathogenic Bacteria, Pharmaceutical, Resistant Bacterial Infection.
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.